THANKSGIVING WEEKEND: Traffic | Travel Guide | Weather | Holiday Guide | Mall Hours


FDA Panel Overwhelmingly Backs Approval Of Anti-Obesity Pill A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.
Taz Goes Big!
Download Now!

Listen Live